- Mandible Advancement Devices
- Tongue Stabilizing Devices
- Nasal Devices
- Continuous Positive Airways Pressure Devices
- Chin Straps
- Others
Anti-Snoring Treatment Market size was valued at USD 4,982.1 million in 2023 , growing at a significant CAGR of 8.9% from 2024-2030. Snoring is a hoarse sound generated when air rushes through relaxed tissues in the throat, causing friction between the tissues and causing vibrations during breathing. Snoring is a frequent occurrence in the population, but it can be a major health issue for some people. Snoring is commonly associated with a sleep problem known as obstructive sleep apnea (OSA) drugs. The mandible advancement devices segment is anticipated to grow at significant CAGR over the forecast years owing to increased demand mandibular advancement device (MAD) are most widely used mouth device for sleep apnea patients. Mandibular advancement device (MAD) resembles a mouth guard used in sports. Moreover, these devices snap over the upper and lower dental arches and have metal hinges that makes it possible for the lower jaw to move forward. Moreover, rising prevalence of sleep apnea and OSAHS, rise in the geriatric population leading to increasing sleep disorder, which is associated with age, and increasing applications of mandibular advancement devices for treatment of snoring and OSA over CPAP systems.
Anti-Snoring Treatment Market Key Developments:
- In February 2021, the United States Food and Drug Administration (US FDA) approved the commercialization of a prescription-only anti-snoring device, ''eXciteOSA'', developed by Rotech Healthcare. It delivers electrical muscle stimulation via a mouthpiece that is placed around the tongue.
Anti-Snoring Treatment Market Summary
Study Period
2024-2030
Base Year
2023
CAGR
8.9%
Largest Market
North America
Fastest Growing Market
Asia Pacific
Anti-Snoring Treatment Market Dynamics
The rising prevalence of different sleep disorders will drive revenue growth in the global anti-snoring therapy market in the approaching years. According to the American Sleep Association, roughly 50-70 million persons in the United States have a sleep disturbance, with 48 percent reporting snoring. Snoring is believed to affect 40% of women and 57% of men in the United States. Obesity, alcohol intake, sedative prescription usage, chronic nasal congestion, and pregnancy are the key factors leading to the rising incidence of snoring. As a result, increased prevalence and awareness of snoring problems will drive market growth.
North America Got Significant Share
Anti-Snoring Treatment Market Regional Analysis
The Anti-Snoring Treatment market in North America is likely to hold the highest revenue share of in 2022 and same trend is expected over the forecast period due to the rising obesity rate and the acceptance of unhealthy lifestyles are fuelling the industry's growth. Thus, the availability of a huge untreated population pool, along with increased alcohol and smoking use, which raises the likelihood of developing snoring condition, would boost sales of anti-snoring devices in the region. Moreover, Presence of large number of players and favourable reimbursement policies are also the factors contributing to the growth of the anti-snoring treatment market.
Latin America
Europe
Asia Pacific
Middle East
North America
Key Features of the Reports
- The report provides granular level information about the market size, regional market share, historic market (2019 to 2023) and forecast (2024 to 2030)
- The report covers in-detail insights about the competitor’s overview, company share analysis, key market developments, and their key strategies
- The report outlines drivers, restraints, unmet needs, and trends that are currently affecting the market
- The report tracks recent innovations, key developments and startup’s details that are actively working in the market
- The report provides plethora of information about market entry strategies, regulatory framework and reimbursement scenario
- The report analyses the impact of socio-political environment through PESTLE Analysis and competition through Porter’s Five Force Analysis in addition to recent technology advancements and innovations in the market
Anti-Snoring Treatment Market Segmentation
By Devices
By Distribution Channel
- Hospitals
- Clinics
- Retail Pharmacies
- E-commerce
- Others
By Geography
- North America
- Europe
- The Asia Pacific
- Latin America
- MEA
Frequently Asked Questions
The key segments covered in the anti-snoring treatment market are: by devices, distribution channel, and geography
The anti-snoring treatment market has been classified into North America, Asia Pacific, Europe, Latin America, Middle East and Africa, and the rest of MEA.
The anti-snoring treatment market key players are: Sleeping Well, LLC (U.S.), Apnea Sciences Corporation (U.S.), Tomed Dr. Toussaint GmbH (Germany), Sleep Well Enjoy Life, Ltd. (U.K.), MEDiTAS Ltd. (U.K.), GSK plc. (U.K.)
| 1.Executive Summary |
| 2.Global Anti-Snoring Treatment Market Introduction |
| 2.1.Global Anti-Snoring Treatment Market - Taxonomy |
| 2.2.Global Anti-Snoring Treatment Market - Definitions |
| 2.2.1.Devices |
| 2.2.2.Distribution Channel |
| 2.2.3.Region |
| 3.Global Anti-Snoring Treatment Market Dynamics |
| 3.1. Drivers |
| 3.2. Restraints |
| 3.3. Opportunities/Unmet Needs of the Market |
| 3.4. Trends |
| 3.5. Product Landscape |
| 3.6. New Product Launches |
| 3.7. Impact of COVID 19 on Market |
| 4.Global Anti-Snoring Treatment Market Analysis, 2019-2023 and Forecast 2024-2030 |
| 4.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million) |
| 4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) |
| 4.3. Market Opportunity Analysis |
| 5.Global Anti-Snoring Treatment Market By Devices, 2019-2023 and Forecast 2024-2030 (Sales Value USD Million) |
| 5.1. Mandible Advancement Devices |
| 5.1.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million) |
| 5.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.1.3. Market Opportunity Analysis |
| 5.2. Tongue Stabilizing Devices |
| 5.2.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million) |
| 5.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.2.3. Market Opportunity Analysis |
| 5.3. Nasal Devices |
| 5.3.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million) |
| 5.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.3.3. Market Opportunity Analysis |
| 5.4. Continuous Positive Airways Pressure Devices |
| 5.4.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million) |
| 5.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.4.3. Market Opportunity Analysis |
| 5.5. Chin Straps |
| 5.5.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million) |
| 5.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.5.3. Market Opportunity Analysis |
| 5.6. Others |
| 5.6.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million) |
| 5.6.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.6.3. Market Opportunity Analysis |
| 6.Global Anti-Snoring Treatment Market By Distribution Channel , 2019-2023 and Forecast 2024-2030 (Sales Value USD Million) |
| 6.1. Hospitals |
| 6.1.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million) |
| 6.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.1.3. Market Opportunity Analysis |
| 6.2. Clinics |
| 6.2.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million) |
| 6.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.2.3. Market Opportunity Analysis |
| 6.3. Retail Pharmacies |
| 6.3.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million) |
| 6.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.3.3. Market Opportunity Analysis |
| 6.4. E-commerce |
| 6.4.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million) |
| 6.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.4.3. Market Opportunity Analysis |
| 6.5. Others |
| 6.5.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million) |
| 6.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.5.3. Market Opportunity Analysis |
| 7.Global Anti-Snoring Treatment Market By Region, 2019-2023 and Forecast 2024-2030 (Sales Value USD Million) |
| 7.1. North America |
| 7.1.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million) |
| 7.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.1.3. Market Opportunity Analysis |
| 7.2. Europe |
| 7.2.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million) |
| 7.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.2.3. Market Opportunity Analysis |
| 7.3. Asia Pacific (APAC) |
| 7.3.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million) |
| 7.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.3.3. Market Opportunity Analysis |
| 7.4. Middle East and Africa (MEA) |
| 7.4.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million) |
| 7.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.4.3. Market Opportunity Analysis |
| 7.5. Latin America |
| 7.5.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million) |
| 7.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.5.3. Market Opportunity Analysis |
| 8.North America Anti-Snoring Treatment Market ,2019-2023 and Forecast 2024-2030 (Sales Value USD Million) |
| 8.1. Devices Analysis 2019-2023 and Forecast 2024-2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 8.1.1.Mandible Advancement Devices |
| 8.1.2.Tongue Stabilizing Devices |
| 8.1.3.Nasal Devices |
| 8.1.4.Continuous Positive Airways Pressure Devices |
| 8.1.5.Chin Straps |
| 8.1.6.Others |
| 8.2. Distribution Channel Analysis 2019-2023 and Forecast 2024-2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 8.2.1.Hospitals |
| 8.2.2.Clinics |
| 8.2.3.Retail Pharmacies |
| 8.2.4.E-commerce |
| 8.2.5.Others |
| 8.3. Country Analysis 2019-2023 and Forecast 2024-2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 8.3.1.United States of America (USA) |
| 8.3.2.Canada |
| 9.Europe Anti-Snoring Treatment Market ,2019-2023 and Forecast 2024-2030 (Sales Value USD Million) |
| 9.1. Devices Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 9.1.1.Mandible Advancement Devices |
| 9.1.2.Tongue Stabilizing Devices |
| 9.1.3.Nasal Devices |
| 9.1.4.Continuous Positive Airways Pressure Devices |
| 9.1.5.Chin Straps |
| 9.1.6.Others |
| 9.2. Distribution Channel Analysis 2019-2023 and Forecast 2024-2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 9.2.1.Hospitals |
| 9.2.2.Clinics |
| 9.2.3.Retail Pharmacies |
| 9.2.4.E-commerce |
| 9.2.5.Others |
| 9.3. Country Analysis 2019-2023 and Forecast 2024-2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 9.3.1.Germany |
| 9.3.2.France |
| 9.3.3.Italy |
| 9.3.4.United Kingdom (UK) |
| 9.3.5.Spain |
| 9.3.6.Rest of EU |
| 10.Asia Pacific (APAC) Anti-Snoring Treatment Market ,2019-2023 and Forecast 2024-2030 (Sales Value USD Million) |
| 10.1. Devices Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 10.1.1.Mandible Advancement Devices |
| 10.1.2.Tongue Stabilizing Devices |
| 10.1.3.Nasal Devices |
| 10.1.4.Continuous Positive Airways Pressure Devices |
| 10.1.5.Chin Straps |
| 10.1.6.Others |
| 10.2. Distribution Channel Analysis 2019-2023 and Forecast 2024-2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 10.2.1.Hospitals |
| 10.2.2.Clinics |
| 10.2.3.Retail Pharmacies |
| 10.2.4.E-commerce |
| 10.2.5.Others |
| 10.3. Country Analysis 2019-2023 and Forecast 2024-2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 10.3.1.China |
| 10.3.2.India |
| 10.3.3.Australia and New Zealand (ANZ) |
| 10.3.4.Japan |
| 10.3.5.Rest of APAC |
| 11.Middle East and Africa (MEA) Anti-Snoring Treatment Market ,2019-2023 and Forecast 2024-2030 (Sales Value USD Million) |
| 11.1. Devices Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 11.1.1.Mandible Advancement Devices |
| 11.1.2.Tongue Stabilizing Devices |
| 11.1.3.Nasal Devices |
| 11.1.4.Continuous Positive Airways Pressure Devices |
| 11.1.5.Chin Straps |
| 11.1.6.Others |
| 11.2. Distribution Channel Analysis 2019-2023 and Forecast 2024-2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 11.2.1.Hospitals |
| 11.2.2.Clinics |
| 11.2.3.Retail Pharmacies |
| 11.2.4.E-commerce |
| 11.2.5.Others |
| 11.3. Country Analysis 2019-2023 and Forecast 2024-2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 11.3.1.GCC Countries |
| 11.3.2.South Africa |
| 11.3.3.Rest of MEA |
| 12.Latin America Anti-Snoring Treatment Market ,2019-2023 and Forecast 2024-2030 (Sales Value USD Million) |
| 12.1. Devices Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 12.1.1.Mandible Advancement Devices |
| 12.1.2.Tongue Stabilizing Devices |
| 12.1.3.Nasal Devices |
| 12.1.4.Continuous Positive Airways Pressure Devices |
| 12.1.5.Chin Straps |
| 12.1.6.Others |
| 12.2. Distribution Channel Analysis 2019-2023 and Forecast 2024-2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 12.2.1.Hospitals |
| 12.2.2.Clinics |
| 12.2.3.Retail Pharmacies |
| 12.2.4.E-commerce |
| 12.2.5.Others |
| 12.3. Country Analysis 2019-2023 and Forecast 2024-2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 12.3.1.Brazil |
| 12.3.2.Mexico |
| 12.3.3.Rest of LA |
| 13. Competition Landscape |
| 13.1. Market Player Profiles (Introduction, Brand/Product Sales, Financial Analysis, Product Offerings, Key Developments, Collaborations, M & A, Strategies, and SWOT Analysis) |
| 13.2.1.Sleeping Well, LLC |
| 13.2.2.Apnea Sciences Corporation |
| 13.2.3.Tomed Dr. Toussaint GmbH |
| 13.2.4.Sleep Well Enjoy Life, Ltd. |
| 13.2.5.MEDiTAS Ltd. |
| 13.2.6.GSK plc. |
| 13.2.8.Contour Products, Inc. |
| 13.2.9.Theravent, Inc. |
| 13.2.10.MPowRx Health & Wellness Products, Inc. |
| 13.2.11.Innovative Health Technologies |
| 14. Research Methodology |
| 15. Appendix and Abbreviations |
- Sleeping Well, LLC
- Apnea Sciences Corporation
- Tomed Dr. Toussaint GmbH
- Sleep Well Enjoy Life, Ltd.
- MEDiTAS Ltd.
- GSK plc.
- HoMedics Group Canada Co
- Contour Products, Inc.
- Theravent, Inc.
- MPowRx Health & Wellness Products, Inc.
- Innovative Health Technologies